Latest filing published 07 Aug 2026 for Axsome Therapeutics, Inc., €193k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Herriot Tabuteau appears in our data through filings on Axsome Therapeutics, Inc. shares, published by SEC (Form 4). The record holds 41 filings, for trades running from 24 November 2015 to 6 August 2026.
The open-market record consists of 20 sales worth €95.3M, with no purchase. The rest of the record consists of 20 option exercises. Since January 2026: no purchases and 8 sales on the market.
The latest filing, published on 7 August 2026, reports an open-market sale of €862k in Axsome Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
19 of 19 declarations